R v Elrayes

In the Supreme Court of South Australia, the Full Court considered questions of law reserved by a District Court Judge concerning a charge against Ayman El Amir Mohammed Elrayes. Elrayes was accused of trafficking in a commercial quantity of a controlled drug, specifically methylamphetamine, or its salt, isomer, or salt of an isomer, contrary to section 32(2) of the *Controlled Substances Act 1984* (SA). The dispute centred on the interpretation of technical terms within Schedule 1 of the Act and Regulation 5 of the *Controlled Substances (General) Regulations 2000* (SA), which define controlled drugs and their various forms.

The legal issues before the Full Court involved the construction and interpretation of these technical terms, particularly how they applied to the definition of a "controlled drug" and the determination of a "commercial quantity" for the purposes of the trafficking offence. Specifically, the court was asked to clarify whether different forms of methylamphetamine, such as its synthetic form, pure form, base form, or salt form, constituted separate controlled drugs or were simply different manifestations of the same controlled drug, methylamphetamine. The court also had to determine how the quantity specified for a "commercial" amount in Schedule 1 applied to these various forms.

The Full Court, adopting reasoning from a previous decision in *R v Willingham*, held that Regulation 5(1) of the *Controlled Substances (General) Regulations 2000* does not create separate controlled drugs for each named form of a substance listed in Schedule 1. Instead, it treats each named form as the same controlled drug. Therefore, methylamphetamine in its synthetic, pure, base, or salt form is all considered methylamphetamine. The court further clarified that the quantity listed as "Commercial (pure)" in Schedule 1 applies to methylamphetamine in its pure or base form, as well as to preparations, admixtures, solutions, and all other forms listed in Regulation 5(1). This means that if the relevant form of methylamphetamine contains the specified amount in its pure form, it constitutes a commercial quantity.

The Full Court answered Question 1.a in the affirmative, confirming that each named form of methylamphetamine is correctly described as the controlled drug methylamphetamine. For Questions 1.b.i and ii, the court ruled that the "Commercial (pure)" quantity applies to methylamphetamine in its pure or base form, and also to methylamphetamine present in any of the forms listed in Regulation 5(1). Question 2 was deemed unnecessary to answer.